These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 31446906

  • 1. Pharmacological and proteomic analyses of neonatal polyI:C-treated adult mice.
    Kitagawa K, Nagai T, Yamada K.
    Neurosci Res; 2019 Oct; 147():39-47. PubMed ID: 31446906
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood.
    Ibi D, Nagai T, Kitahara Y, Mizoguchi H, Koike H, Shiraki A, Takuma K, Kamei H, Noda Y, Nitta A, Nabeshima T, Yoneda Y, Yamada K.
    Neurosci Res; 2009 Jul; 64(3):297-305. PubMed ID: 19447299
    [Abstract] [Full Text] [Related]

  • 5. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia.
    Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, Iyo M.
    Biol Psychiatry; 2006 Mar 15; 59(6):546-54. PubMed ID: 16256957
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood.
    Ibi D, Nagai T, Koike H, Kitahara Y, Mizoguchi H, Niwa M, Jaaro-Peled H, Nitta A, Yoneda Y, Nabeshima T, Sawa A, Yamada K.
    Behav Brain Res; 2010 Jan 05; 206(1):32-7. PubMed ID: 19716847
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [PolyI:C-induced neurodevelopmental animal model for schizophrenia].
    Ibi D, Nagai T, Nabeshima T, Yamada K.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov 05; 31(5-6):201-7. PubMed ID: 22256608
    [Abstract] [Full Text] [Related]

  • 15. The 5α-reductase inhibitor finasteride increases suicide-related aggressive behaviors and blocks clozapine-induced beneficial effects in an animal model of schizophrenia.
    Maurice-Gélinas C, Deslauriers J, Monpays C, Sarret P, Grignon S.
    Physiol Behav; 2018 Jul 01; 191():65-72. PubMed ID: 29630964
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.
    Gomes FV, Issy AC, Ferreira FR, Viveros MP, Del Bel EA, Guimarães FS.
    Int J Neuropsychopharmacol; 2014 Oct 31; 18(5):. PubMed ID: 25618402
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.